Opportunity Information: Apply for RFA FD 22 023

  • The Department of Health and Human Services, Food and Drug Administration in the consumer protection, science and technology and other research and development sector is offering a public funding opportunity titled "Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks and Pediatric Anesthesia Safety Initiative (ACTTION/PASI) (U01) Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103.
  • This funding opportunity was created on Feb 07, 2022.
  • Applicants must submit their applications by Apr 11, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2024.)
  • Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses.
Apply for RFA FD 22 023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: Department of Health and Human Services, Food and Drug Administration

Browse more opportunities from the same category: Consumer Protection, Science and Technology and other Research and Development

Next opportunity: Countering Malign Economic Influence

Previous opportunity: Fiscal Year 2021 Staffing for Adequate Fire and Emergency Response (SAFER) Grant

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA FD 22 023

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA FD 22 023) also looked into and applied for these:

Funding Opportunity
Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional Apply for RFA FD 22 026

Funding Number: RFA FD 22 026
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $1,000,000
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required Apply for FOR FD 23 007

Funding Number: FOR FD 23 007
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $650,000
Designing and performing a virtual bioequivalence trial for physiologically-based pharmacokinetic and other mechanism-based models Apply for RFA FD 23 016

Funding Number: RFA FD 23 016
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $500,000
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed Apply for RFA FD 23 012

Funding Number: RFA FD 23 012
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $1,200,000
Evaluation of oral modified release drug tablet to support the approval of additional strengths Apply for RFA FD 23 013

Funding Number: RFA FD 23 013
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $450,000
Novel approaches to support therapeutic development in ultra-rare cancers Apply for RFA FD 23 008

Funding Number: RFA FD 23 008
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $2,500,000
In Vitro Based Approaches to Evaluate the Bioequivalence of Prospective Generic Rectal and Vaginal Products (U01) Clinical Trial Not Allowed Apply for RFA FD 23 014

Funding Number: RFA FD 23 014
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $1,000,000
Applied Regulatory Science Research to Understand Factors that Affect the Safety and Efficacy of Underrepresented Populations in Oncology Therapeutic Development (U01) Clinical Trial Optional Apply for RFA FD 23 006

Funding Number: RFA FD 23 006
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $2,500,000
Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed. Apply for RFA FD 23 007

Funding Number: RFA FD 23 007
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $300,000
Development and Validation of a Multi-functional, Multi-purpose Quantitative Tool for Dermal Physiologically-Based Pharmacokinetic (PBPK) Modeling (U01) Clinical Trial Optional Apply for RFA FD 23 015

Funding Number: RFA FD 23 015
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $750,000
Pediatric Device Consortia Grants Program (P50) Clinical Trials Optional Apply for RFA FD 23 024

Funding Number: RFA FD 23 024
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $5,000,000
Natural History and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional Apply for RFA FD 23 028

Funding Number: RFA FD 23 028
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $2,000,000
Education and Training Program for Outsourcing Facility Industry (UE5) Clinical Trials Not Allowed Apply for RFA FD 23 029

Funding Number: RFA FD 23 029
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $5,500,000
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required Apply for RFA FD 23 001

Funding Number: RFA FD 23 001
Agency: Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $650,000
Population Pharmacokinetic Modeling of Systemic Pharmacokinetic Data to Inform Bioequivalence in Regional Lung Exposure (U01) Clinical Trial Not Allowed Apply for RFA FD 23 017

Funding Number: RFA FD 23 017
Agency: Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $500,000
Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional Apply for RFA FD 23 026

Funding Number: RFA FD 23 026
Agency: Food and Drug Administration
Category: Consumer Protection, Science and Technology and other Research and Development
Funding Amount: $2,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 22 023", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: